文献速递创伤与烧伤重症综合管理与镇静镇痛

溯源而上:无细胞血浆中波动性血小板特异性基因作为概念验证,利用核糖核酸测序增进对创伤后血小板生物学的理解

A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论在孤立性重型致命性创伤性脑损伤患者无细胞血浆中,发现42个差异剪接的活化血小板特异性RNA转录本(34个基因),支持将血小板RNA转录本调控作为上游「液体活检」探索创伤后血小板生物学。

该研究应用高读取深度RNA测序检测无细胞血浆,比较10例孤立性重型致命性创伤性脑损伤患者(头AIS≥3、其他部位AIS<3、死亡)与5例轻微伤创伤对照(ISS≤1、存活)的活化血小板特异性剪接RNA转录本,并以23例健康对照的公开无细胞血浆RNA测序数据集过滤。结果在致命性创伤性脑损伤患者无细胞血浆中鉴定出34个基因中的42个差异剪接的活化血小板特异性RNA转录本(上调与下调并存)。作者认为这提示损伤后存在一群未成熟血小板RNA发生剪接事件,可能用于调控参与血小板功能的血小板蛋白产物,从而验证了将损伤诱导的血小板RNA转录本调控作为上游「液体活检」来发现新的创伤后血小板生物学与治疗靶点的探索方向。证据等级为诊断性试验V级。

要点

  • 在10例孤立性重型致命性创伤性脑损伤患者(头AIS≥3、其他部位AIS<3、死亡)的无细胞血浆中,发现34个基因的42个活化血小板特异性剪接RNA转录本较轻微伤创伤对照(ISS≤1、存活)上调或下调。
  • 研究以23例健康对照的公开无细胞血浆RNA测序数据集确定剪接形式RNA转录本的相对稳态,用于过滤可发现的转录本。
  • 活化血小板特异性剪接RNA转录本来源于体外血小板活化研究,以剪接连接存在大于1.5倍或小于0.67倍体外未活化血小板特异性RNA转录本为鉴定标准。
  • 作者认为损伤后一群未成熟血小板RNA发生剪接事件,可能用于调控参与血小板功能的血小板蛋白产物。
  • 作者认为该概念验证支持将损伤诱导的血小板RNA转录本调控作为上游「液体活检」,以识别新的创伤后血小板生物学与异常血小板行为的治疗靶点。

适用人群与场景

  • 10例孤立性重型致命性创伤性脑损伤患者:头AIS≥3、所有其他类别AIS<3、死亡。
  • 5例轻微伤创伤对照:ISS≤1、存活。
  • 23例健康对照:使用公开可得的无细胞血浆RNA测序数据集。

诊断标准与关键阈值

  • 活化血小板特异性剪接RNA转录本鉴定标准:剪接连接存在大于1.5倍或小于0.67倍体外未活化血小板特异性RNA转录本。

研究设计与关键结果

  • 研究类型:概念验证研究,应用高读取深度RNA测序检测无细胞血浆。
  • 样本量:10例致命性创伤性脑损伤患者、5例轻微伤创伤对照,并以23例健康对照公开无细胞血浆RNA测序数据集过滤。
  • 主要结果:在致命性创伤性脑损伤患者无细胞血浆中,34个基因中的42个差异剪接的活化血小板特异性RNA转录本发生改变(上调与下调并存)。

证据类型、等级与局限

  • 证据类型:诊断性试验,证据等级V级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该概念验证提示损伤后未成熟血小板RNA发生剪接事件,可能用于调控参与血小板功能的血小板蛋白产物。
  • 作者认为该研究验证了将损伤诱导的血小板RNA转录本调控作为上游「液体活检」来识别新的创伤后血小板生物学与异常血小板行为治疗靶点的探索。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The mechanisms of aberrant circulating platelet behavior following injury remain unclear. Platelets retain megakaryocyte immature ribonucleic acid (RNA) splicing and protein synthesis machinery to alter their functions based on physiologic signals. We sought to identify fluctuating platelet-specific RNA transcripts in cell-free plasma (CFP) from traumatic brain injury (TBI) patients as proof-of-concept for using RNA sequencing to improve our understanding of postinjury platelet behavior. We hypothesized that we could identify differential expression of activated platelet-specific spliced RNA transcripts from CFP of patients with isolated severe fatal TBI (fTBI) compared with minimally injured trauma controls (t-controls), filtered by healthy control (h-control) data sets.

METHODS: High-read depth RNA sequencing was applied to CFP from 10 patients with fTBI (Abbreviated Injury Scale [AIS] for head ≥3, AIS for all other categories <3, and expired) and five t-controls (Injury Severity Score ≤1, and survived). A publicly available CFP RNA sequencing data set from 23 h-controls was used to determine the relative steady state of splice-form RNA transcripts discoverable in CFP. Activated platelet-specific spliced RNA transcripts were derived from studies of ex vivo platelet activation and identified by splice junction presence greater than 1.5-fold or less than 0.67-fold ex vivo nonactivated platelet-specific RNA transcripts.

RESULTS: Forty-two differentially spliced activated platelet-specific RNA transcripts in 34 genes were altered in CFP from fTBI patients (both upregulated and downregulated).

CONCLUSION: We have discovered differentially expressed activated platelet-specific spliced RNA transcripts present in CFP from isolated severe fTBI patients that are upregulated or downregulated compared with minimally injured trauma controls. This proof-of-concept suggests that a pool of immature platelet RNAs undergo splicing events after injury for presumed modulation of platelet protein products involved in platelet function. This validates our exploration of injury-induced platelet RNA transcript modulation as an upstream "liquid biopsy" to identify novel postinjury platelet biology and treatment targets for aberrant platelet behavior.

LEVEL OF EVIDENCE: Diagnostic tests, level V.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Kornblith LZ, Bainton CMV, Fields AT, et al. A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology. J Trauma Acute Care Surg. 2020. PMID: 32195992. doi:10.1097/TA.0000000000002681

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。